864

Pawlikowska L, Hu D, Huntsman S, et al. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell. 2009;8(4):460–72. https://pubmed.ncbi.nlm.nih.gov/19489743/

865

Ben-Avraham D, Govindaraju DR, Budagov T, et al. The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature. Sci Adv. 2017;3(6):e1602025. https://pubmed.ncbi.nlm.nih.gov/28630896/

866

Teumer A, Qi Q, Nethander M, et al. Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits. Aging Cell. 2016;15(5):811–24. https://pubmed.ncbi.nlm.nih.gov/27329260/

867

Milman S, Atzmon G, Huffman DM, et al. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell. 2014;13(4):769–71. https://pubmed.ncbi.nlm.nih.gov/24618355/

868

van der Spoel E, Rozing MP, Houwing-Duistermaat JJ, et al. Association analysis of insulin-like growth factor-1 axis parameters with survival and functional status in nonagenarians of the Leiden Longevity Study. Aging (Albany NY). 2015;7(11):956–63. https://pubmed.ncbi.nlm.nih.gov/26568155/

869

Suh Y, Atzmon G, Cho MO, et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A. 2008;105(9):3438–42. https://pubmed.ncbi.nlm.nih.gov/18316725/

870

Tazearslan C, Huang J, Barzilai N, Suh Y. Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles. Aging Cell. 2011;10(3):551–4. https://pubmed.ncbi.nlm.nih.gov/21388493/

871

Bartke A. Healthy aging: is smaller better? – a mini-review. Gerontology. 2012;58(4):337–43. https://pubmed.ncbi.nlm.nih.gov/22261798/

872

Michell AR. Longevity of British breeds of dog and its relationships with sex, size, cardiovascular variables and disease. Vet Rec. 1999;145(22):625–9. https://pubmed.ncbi.nlm.nih.gov/10619607/

873

Sutter NB, Bustamante CD, Chase K, et al. A single IGF1 allele is a major determinant of small size in dogs. Science. 2007;316(5821):112–5. https://pubmed.ncbi.nlm.nih.gov/17412960/

874

Samaras TT. How height is related to our health and longevity: a review. Nutr Health. 2012;21(4):247–61. https://pubmed.ncbi.nlm.nih.gov/24620006/

875

Sohn K. Now, the taller die earlier: the curse of cancer. J Gerontol A Biol Sci Med Sci. 2016;71(6):713–9. https://pubmed.ncbi.nlm.nih.gov/25991828/

876

Samaras TT. How height is related to our health and longevity: a review. Nutr Health. 2012;21(4):247–61. https://pubmed.ncbi.nlm.nih.gov/24620006/

877

Samaras TT, Elrick H, Storms LH. Is height related to longevity? Life Sci. 2003;72(16):1781–802. https://pubmed.ncbi.nlm.nih.gov/12586217/

878

Samaras TT. How height is related to our health and longevity: a review. Nutr Health. 2012;21(4):247–61. https://pubmed.ncbi.nlm.nih.gov/24620006/

879

Один дюйм равен 2,54 см. – Примеч. ред.

880

Sohn K. Now, the taller die earlier: the curse of cancer. J Gerontol A Biol Sci Med Sci. 2016;71(6):713–9. https://pubmed.ncbi.nlm.nih.gov/25991828/

881

Walter RB, Brasky TM, Buckley SA, Potter JD, White E. Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst. 2013;105(12):860–8. https://pubmed.ncbi.nlm.nih.gov/23708052/

882

Shors AR, Solomon C, McTiernan A, White E. Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control. 2001;12(7):599–606. https://pubmed.ncbi.nlm.nih.gov/11552707/

883

Walter RB, Brasky TM, Buckley SA, Potter JD, White E. Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst. 2013;105(12):860–8. https://pubmed.ncbi.nlm.nih.gov/23708052/

884

Suh Y, Atzmon G, Cho MO, et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A. 2008;105(9):3438–42. https://pubmed.ncbi.nlm.nih.gov/18316725/

885

Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol. 1999;17(9):2941–53. https://pubmed.ncbi.nlm.nih.gov/10561374/

886

Murphy N, Knuppel A, Papadimitriou N, et al. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ~430 000 women. Ann Oncol. 2020;31(5):641–9. https://pubmed.ncbi.nlm.nih.gov/32169310/

887

Chi F, Wu R, Zeng Y, Xing R, Liu Y. Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis. Mol Biol Rep. 2013;40(5):3583–90. https://pubmed.ncbi.nlm.nih.gov/23269623/

888

Travis RC, Appleby PN, Martin RM, et al. A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk. Cancer Res. 2016;76(8):2288–300. https://pubmed.ncbi.nlm.nih.gov/26921328/

889

Cao H, Wang G, Meng L, et al. Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis. PLoS One. 2012;7(11):e49884. https://pubmed.ncbi.nlm.nih.gov/23185474/

890

Li Y, Li Y, Zhang J, et al. Circulating insulin-like growth factor-1 level and ovarian cancer risk. Cell Physiol Biochem. 2016;38(2):589–97. https://pubmed.ncbi.nlm.nih.gov/26845340/

891

Gong Y, Zhang B, Liao Y, et al. Serum insulin-like growth factor axis and the risk of pancreatic cancer: systematic review and meta-analysis. Nutrients. 2017;9(4):394. https://pubmed.ncbi.nlm.nih.gov/28420208/

892

Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet. 1998;351(9113):1393–6. https://pubmed.ncbi.nlm.nih.gov/9593409/

893

Yee D. Insulin-like growth factor receptor inhibitors: baby or the bathwater? J Natl Cancer Inst. 2012;104(13):975–81. https://pubmed.ncbi.nlm.nih.gov/22761272/

894

Quan H, Tang H, Fang L, Bi J, Liu Y, Li H. IGF1(CA)19 and IGFBP-3–202A/C gene polymorphism and cancer risk: a meta-analysis. Cell Biochem Biophys. 2014;69(1):169–78. https://pubmed.ncbi.nlm.nih.gov/24310658/

895

Yokoyama NN, Denmon AP, Uchio EM, Jordan M, Mercola D, Zi X. When anti-aging studies meet cancer chemoprevention: can anti-aging agent kill two birds with one blow? Curr Pharmacol Rep. 2015;1(6):420–33. https://pubmed.ncbi.nlm.nih.gov/26756023/

896

Elia I, Doglioni G, Fendt SM. Metabolic hallmarks of metastasis formation. Trends Cell Biol. 2018;28(8):673–84. https://pubmed.ncbi.nlm.nih.gov/29747903/

897

Kleinberg DL, Wood TL, Furth PA, Lee AV. Growth hormone